Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin

J Infect Chemother. 2003 Mar;9(1):62-7; discussion 104-5. doi: 10.1007/s10156-002-0215-5.

Abstract

A sudden increase in vancomycin-resistant enterococci (VRE) infections was noted in 1998 in a tertiary care hospital in Korea. All of the VRE isolated in 1998 in the hospital were VanA type and most were multidrug-resistant Enterococcus faecium. The increase in VRE was probably due to the increased use of oral vancomycin to treat Clostridium difficile infections and clonal as well as horizontal spread. More restricted oral vancomycin use and stricter infection control measures are required to achieve a better control of the spread of VRE.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Anti-Bacterial Agents / pharmacology
  • Child, Preschool
  • Clostridioides difficile / drug effects
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Electrophoresis, Gel, Pulsed-Field
  • Enterococcus / classification
  • Enterococcus / drug effects*
  • Enterococcus / genetics
  • Enterococcus / isolation & purification
  • Enterococcus faecium / classification
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / genetics
  • Enterococcus faecium / isolation & purification
  • Enterocolitis, Pseudomembranous / drug therapy
  • Enterocolitis, Pseudomembranous / microbiology
  • Female
  • Gram-Positive Bacterial Infections / epidemiology*
  • Gram-Positive Bacterial Infections / microbiology
  • Hospitals, Urban*
  • Humans
  • Korea
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Plasmids
  • Polymerase Chain Reaction
  • Vancomycin / administration & dosage
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use
  • Vancomycin Resistance* / genetics

Substances

  • Anti-Bacterial Agents
  • Vancomycin